Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 2.42 USD -2.02% Market Closed
Market Cap: 504.9m USD
Have any thoughts about
Sangamo Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sangamo Therapeutics Inc

Current Assets 58.1m
Cash & Short-Term Investments 39.2m
Receivables 10.5m
Other Current Assets 8.4m
Non-Current Assets 53.1m
PP&E 36.9m
Other Non-Current Assets 16.2m
Current Liabilities 43.2m
Accounts Payable 19.8m
Accrued Liabilities 22.6m
Other Current Liabilities 774k
Non-Current Liabilities 29m
Other Non-Current Liabilities 29m

Balance Sheet
Sangamo Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
6
70
22
50
140
80
131
179
100
45
Cash Equivalents
6
70
22
50
140
80
131
179
100
45
Short-Term Investments
173
140
121
194
260
282
510
198
177
36
Total Receivables
11
3
5
4
5
38
6
6
5
1
Accounts Receivables
10
3
5
3
5
37
5
6
4
1
Other Receivables
0
0
0
0
0
1
1
0
1
0
Other Current Assets
1
1
2
2
5
5
12
16
18
12
Total Current Assets
191
213
150
248
411
406
660
399
300
94
PP&E Net
2
3
7
31
79
107
112
125
126
53
PP&E Gross
2
3
7
31
79
107
112
125
126
53
Accumulated Depreciation
4
5
6
7
9
12
17
25
37
51
Intangible Assets
2
0
0
0
55
53
58
54
51
0
Goodwill
2
2
2
2
40
39
43
40
38
0
Long-Term Investments
47
0
0
1
0
22
51
88
30
0
Other Long-Term Assets
0
0
0
5
6
11
15
17
19
18
Other Assets
2
2
2
2
40
39
43
40
38
0
Total Assets
243
N/A
217
-11%
158
-27%
287
+82%
590
+106%
638
+8%
939
+47%
722
-23%
563
-22%
165
-71%
Liabilities
Accounts Payable
6
4
3
0
3
7
6
10
22
15
Accrued Liabilities
6
7
6
15
22
22
49
31
34
21
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
10
10
5
30
53
41
101
88
55
12
Total Current Liabilities
21
20
13
45
79
70
144
128
112
48
Long-Term Debt
0
0
4
25
0
0
0
0
0
0
Deferred Income Tax
1
0
0
0
7
7
7
7
6
0
Minority Interest
0
0
0
0
1
0
1
0
0
0
Other Liabilities
15
5
5
29
138
128
291
212
150
35
Total Liabilities
37
N/A
25
-32%
22
-13%
99
+355%
224
+127%
205
-8%
440
+115%
347
-21%
268
-23%
82
-69%
Equity
Common Stock
1
1
1
1
1
1
1
2
2
2
Retained Earnings
329
369
441
496
563
657
778
956
1 149
1 406
Additional Paid In Capital
535
561
576
683
930
1 091
1 269
1 334
1 450
1 492
Other Equity
0
0
0
0
1
2
5
4
8
5
Total Equity
207
N/A
192
-7%
136
-29%
188
+38%
367
+95%
433
+18%
498
+15%
375
-25%
295
-21%
83
-72%
Total Liabilities & Equity
243
N/A
217
-11%
158
-27%
287
+82%
590
+106%
638
+8%
939
+47%
722
-23%
563
-22%
165
-71%
Shares Outstanding
Common Shares Outstanding
69
70
71
86
102
116
142
146
167
178

See Also

Discover More